Market News AIOpen the app

ASMB stock news · Assembly Biosciences, Inc.

Stories about Assembly Biosciences, Inc. (ASMB) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ASMB

Follow Assembly Biosciences, Inc. (ASMB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ASMB
Free on the App Store and Google Play, or on the web.
  1. Nov 3, 2026, 7:23 PM ET · Opinion

    UBS has cut its price target for Assembly Biosciences from $52 to $48 but still thinks it's a good buy.

    Neutral

    UBS cut its ASMB target by $4 per share, from $52 to $48, but kept its Buy rating. The mixed view does not change the company's outlook.